Free Trial

Charles Schwab Investment Management Inc. Purchases 173,532 Shares of Neogen Corporation $NEOG

Neogen logo with Medical background

Key Points

  • Charles Schwab Investment Management Inc. increased its stake in Neogen Corporation by 8.4%, acquiring an additional 173,532 shares during the first quarter, bringing its total to 2,235,459 shares worth approximately $19.4 million.
  • Institutional ownership of Neogen stands at 96.73%, with significant increases in holdings reported by several other investors, including a 90.3% increase by Principal Financial Group Inc.
  • Despite recent investments, Neogen's stock has received mixed analyst ratings, with a current consensus rating of "Hold" and an average price target of $7.50.
  • Looking to export and analyze Neogen data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Charles Schwab Investment Management Inc. increased its holdings in shares of Neogen Corporation (NASDAQ:NEOG - Free Report) by 8.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,235,459 shares of the company's stock after acquiring an additional 173,532 shares during the period. Charles Schwab Investment Management Inc. owned about 1.03% of Neogen worth $19,381,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. Principal Financial Group Inc. increased its position in Neogen by 90.3% in the 1st quarter. Principal Financial Group Inc. now owns 1,123,391 shares of the company's stock valued at $9,740,000 after acquiring an additional 533,064 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in shares of Neogen by 212.9% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 107,395 shares of the company's stock worth $931,000 after purchasing an additional 73,071 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Neogen by 24.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 6,939,984 shares of the company's stock worth $84,254,000 after purchasing an additional 1,345,056 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Neogen in the 4th quarter valued at approximately $2,744,000. Finally, State of Alaska Department of Revenue increased its position in shares of Neogen by 386.2% during the first quarter. State of Alaska Department of Revenue now owns 109,387 shares of the company's stock worth $948,000 after acquiring an additional 86,887 shares in the last quarter. 96.73% of the stock is currently owned by institutional investors.

Neogen Trading Up 0.5%

NASDAQ NEOG opened at $5.60 on Friday. The firm has a market capitalization of $1.22 billion, a PE ratio of -1.11 and a beta of 1.79. The business's 50-day moving average price is $5.11 and its two-hundred day moving average price is $6.67. The company has a current ratio of 3.32, a quick ratio of 2.22 and a debt-to-equity ratio of 0.42. Neogen Corporation has a 12 month low of $3.87 and a 12 month high of $17.95.

Analyst Ratings Changes

NEOG has been the subject of a number of recent research reports. William Blair downgraded shares of Neogen from an "outperform" rating to a "market perform" rating in a research note on Tuesday, July 29th. Guggenheim decreased their target price on Neogen from $13.00 to $10.00 and set a "buy" rating on the stock in a research report on Monday, June 30th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $7.50.

View Our Latest Stock Report on NEOG

About Neogen

(Free Report)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.

See Also

Institutional Ownership by Quarter for Neogen (NASDAQ:NEOG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Neogen Right Now?

Before you consider Neogen, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neogen wasn't on the list.

While Neogen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines